Literature DB >> 18486725

Chemotherapy for malignant pleural mesothelioma.

Nicholas J Vogelzang1.   

Abstract

Entities:  

Mesh:

Year:  2008        PMID: 18486725     DOI: 10.1016/S0140-6736(08)60703-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

Review 1.  Novel systemic therapy against malignant pleural mesothelioma.

Authors:  Michael R Mancuso; Joel W Neal
Journal:  Transl Lung Cancer Res       Date:  2017-06

Review 2.  The role of interleukin-6 in malignant mesothelioma.

Authors:  Siti N Abdul Rahim; Gwo Y Ho; Jermaine I G Coward
Journal:  Transl Lung Cancer Res       Date:  2015-02

3.  Oncolytic measles viruses encoding interferon beta and the thyroidal sodium iodide symporter gene for mesothelioma virotherapy.

Authors:  H Li; K-W Peng; D Dingli; R A Kratzke; S J Russell
Journal:  Cancer Gene Ther       Date:  2010-04-09       Impact factor: 5.987

4.  Progranulin and granulin-like protein as novel VEGF-independent angiogenic factors derived from human mesothelioma cells.

Authors:  R Eguchi; T Nakano; I Wakabayashi
Journal:  Oncogene       Date:  2016-06-27       Impact factor: 9.867

5.  Serum concentration of integrin-linked kinase in malignant pleural mesothelioma and after asbestos exposure.

Authors:  Stefan B Watzka; Florian Posch; Harvey I Pass; Raja M Flores; Gregory E Hannigan; David Bernhard; Michael Weber; Michael R Mueller
Journal:  Eur J Cardiothorac Surg       Date:  2012-10-07       Impact factor: 4.191

Review 6.  Novel oncolytic viral therapies in patients with thoracic malignancies.

Authors:  Zeeshan Ahmad; Robert A Kratzke
Journal:  Oncolytic Virother       Date:  2016-12-21

7.  Isolated thoracic perfusion with chemofiltration for progressive malignant pleural mesothelioma.

Authors:  Karl Reinhard Aigner; Emir Selak; Sabine Gailhofer
Journal:  Onco Targets Ther       Date:  2017-06-19       Impact factor: 4.147

8.  A proteomics-based approach identifies secreted protein acidic and rich in cysteine as a prognostic biomarker in malignant pleural mesothelioma.

Authors:  Steven C Kao; Michaela B Kirschner; Wendy A Cooper; Thang Tran; Sjaak Burgers; Casey Wright; Tiny Korse; Daan van den Broek; James Edelman; Michael Vallely; Brian McCaughan; Nick Pavlakis; Stephen Clarke; Mark P Molloy; Nico van Zandwijk; Glen Reid
Journal:  Br J Cancer       Date:  2016-02-18       Impact factor: 7.640

9.  Quality of Life Is Not Deteriorated After Extrapleural Pneumonectomy vs. (Extended) Pleurectomy/Decortication in Patients With Malignant Pleural Mesothelioma.

Authors:  Olivia Lauk; Miriam Patella; Thomas Neuer; Ilhan Inci; Walter Weder; Isabelle Opitz
Journal:  Front Surg       Date:  2021-12-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.